T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$3.15B |
| 2 |
Global Payments
GPN
|
+$2B |
| 3 |
NextEra Energy
NEE
|
+$1.82B |
| 4 |
Salesforce
CRM
|
+$1.51B |
| 5 |
Boeing
BA
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$3.23B |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$1.76B |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$1.49B |
| 4 |
Bank of America
BAC
|
+$1.43B |
| 5 |
Elevance Health
ELV
|
+$1.39B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 15.83% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Blackstone
BX
$112B
| $15.2M | ﹤0.01% |
+310,600
| New | +$15.1M |
|
1227
FS Bancorp
FSBW
$326M
| $15.2M | ﹤0.01% |
577,206
+50,884
| +10% | +$1.26M |
|
1228
Worthington Enterprises
WOR
$2.85B
| $15.1M | ﹤0.01% |
679,495
-7,347
| -1% | -$170K |
|
1229
RGC Resources
RGCO
$226M
| $15M | ﹤0.01% |
512,841
+1,502
| +0.3% | +$42.8K |
|
1230
DXC Technology
DXC
$1.79B
| $14.8M | ﹤0.01% |
500,057
+6,457
| +1% | +$275K |
|
1231
NOV
NOV
$7.36B
| $14.7M | ﹤0.01% |
695,334
+2,801
| +0.4% | +$59.7K |
|
1232
Zions Bancorporation
ZION
$10.5B
| $14.7M | ﹤0.01% |
329,670
-787
| -0.2% | -$34K |
|
|
IGMS
1233
DELISTED
IGM Biosciences
IGMS
| $14.5M | ﹤0.01% |
+815,279
| New | +$16.5M |
|
1234
Axsome Therapeutics
AXSM
$11.2B
| $14.3M | ﹤0.01% |
708,871
+130,012
| +22% | +$3.34M |
|
|
AUTL
1235
Autolus Therapeutics
AUTL
$591M
| $14.3M | ﹤0.01% |
1,149,729
-30,667
| -3% | -$405K |
|
1236
Newell Brands
NWL
$2.63B
| $14.2M | ﹤0.01% |
757,863
-19,596
| -3% | -$316K |
|
|
WW
1237
DELISTED
WW International
WW
| $14.1M | ﹤0.01% |
373,071
-9,118
| -2% | -$257K |
|
1238
BorgWarner
BWA
$13.8B
| $14.1M | ﹤0.01% |
435,496
+271
| +0.1% | +$8.73K |
|
|
PROS
1239
DELISTED
ProSight Global, Inc.
PROS
| $13.9M | ﹤0.01% |
+716,698
| New | +$13.1M |
|
1240
uniQure
QURE
$3.26B
| $13.7M | ﹤0.01% |
347,096
+908
| +0.3% | +$52.4K |
|
1241
Q2 Holdings
QTWO
$4.13B
| $13.6M | ﹤0.01% |
172,704
-343,213
| -67% | -$28.4M |
|
1242
AMN Healthcare
AMN
$1.34B
| $13.5M | ﹤0.01% |
235,203
+195,246
| +489% | +$10.8M |
|
1243
Albemarle
ALB
$15.4B
| $13.4M | ﹤0.01% |
192,535
-11,407
| -6% | -$777K |
|
1244
Copa Holdings
CPA
$6.17B
| $13.2M | ﹤0.01% |
133,421
+5,701
| +4% | +$574K |
|
1245
Phibro Animal Health
PAHC
$1.38B
| $13.1M | ﹤0.01% |
614,089
+1,625
| +0.3% | +$44.5K |
|
1246
The Mosaic Company
MOS
$6.92B
| $13.1M | ﹤0.01% |
638,353
+1,050
| +0.2% | +$22.9K |
|
1247
Resideo Technologies
REZI
$3.1B
| $12.9M | ﹤0.01% |
900,469
-667,661
| -43% | -$11.2M |
|
1248
Invesco
IVZ
$14.3B
| $12.9M | ﹤0.01% |
761,597
-5,070
| -0.7% | -$89.5K |
|
|
ICPT
1249
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $12.8M | ﹤0.01% |
193,179
-1,394
| -0.7% | -$93.6K |
|
|
MGP
1250
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $12.8M | ﹤0.01% |
426,569
+84,126
| +25% | +$2.53M |
|
Similar funds
T. Rowe Price Associates's Q3 2019 Portfolio in Review
As of Q3 2019, T. Rowe Price Associates held 2,592 positions worth $706B, down 0.8% from $712B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 4.9%. T. Rowe Price Associates opened 52 new positions and exited 74, leaving the 2,592-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2019 buy was The Southern Company: 9,440,159 shares worth $502M.
- T. Rowe Price Associates added most to Fidelity National Information Services in Q3 2019, an estimated $3.15B increase.
- T. Rowe Price Associates's biggest Q3 2019 reduction was Bank of America, cutting an estimated $1.43B.
- T. Rowe Price Associates fully exited Worldpay, Inc. in Q3 2019, selling an estimated $3.23B.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $706B portfolio in Q3 2019.
- T. Rowe Price Associates opened 52 new positions and closed 74 in Q3 2019.
- T. Rowe Price Associates's portfolio value fell 0.8% quarter-over-quarter to $706B.
Based on T. Rowe Price Associates's 13F filing for Q3 2019, filed 14 Nov 2019.